Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Innolux Corporation, formed through the landmark merger of Chi Mei Optoelectronics, TPO Displays, and Innolux Display Corp, is a global leader in TFT-LCD technology with a robust dedicated healthcare business unit. The company leverages its advanced thin-film transistor (TFT) expertise to develop and manufacture high-precision medical imaging components, most notably digital X-ray flat panel detectors (FPD). Through its subsidiary InnoCare Optoelectronics, Innolux provides critical sensing technology for diagnostic radiography, mammography, and surgical visualization systems. As a key OEM/ODM partner for major global medical device brands, the company plays a vital role in the transition from analog to digital medical imaging. Their product portfolio also includes high-resolution medical diagnostic displays designed for clinical review and surgical environments.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Chi Mei Optoelectronics.